HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induced pluripotent stem cells from homozygous Runx2-deficient mice show poor response to vitamin D during osteoblastic differentiation.

Abstract
Cleidocranial dysplasia (CCD) is a hereditary disorder associated with skeletal dysplasia and dental abnormalities. CCD arises from heterozygous loss of function mutations in the Runt-related transcription factor 2 (RUNX2) gene. Osteoporosis is often observed in CCD patients and conventional vitamin D supplementation is recommended. However, sufficient evidences have not been presented yet. This study investigated the role of RUNX2 in osteoblastic differentiation and sought to identify potential target genes for the treatment of osteoporosis associated with CCD, using induced pluripotent stem cell (iPSC) technology. We successfully established Runx2-/-, Runx2+/- and wild-type miPSCs from litter-matched mice and found poor Vdr expression in Runx2-/-cells. Significant down-regulation of osteoblastic differentiation in Runx2-/- miPSCs was observed. Gene expression array revealed unexpected results such as remarkable increase of Rankl expression and decrease of Vdr in Runx2-/- cells. Insufficient response to vitamin D in Runx2-/- cells was also observed. Our results suggest that RUNX2 functions as a regulator of Rankl and Vdr and thereby controls bone density. These findings also suggest that conventional vitamin D supplementation may not be as effective as previously expected, in the treatment of osteoporosis associated with CCD, and that inhibiting RANKL function might be worth considering as an alternative treatment strategy.
AuthorsHideto Aoki, Eiichi Suzuki, Takashi Nakamura, Shoko Onodera, Akiko Saito, Manami Ohtaka, Mahito Nakanishi, Ken Nishimura, Atsushi Saito, Toshifumi Azuma
JournalMedical molecular morphology (Med Mol Morphol) Vol. 55 Issue 3 Pg. 174-186 (Sep 2022) ISSN: 1860-1499 [Electronic] Japan
PMID35461467 (Publication Type: Journal Article)
Copyright© 2022. The Author(s) under exclusive licence to The Japanese Society for Clinical Molecular Morphology.
Chemical References
  • Core Binding Factor Alpha 1 Subunit
  • Runx2 protein, mouse
  • Vitamin D
Topics
  • Animals
  • Cell Differentiation
  • Cleidocranial Dysplasia (genetics)
  • Core Binding Factor Alpha 1 Subunit (genetics, metabolism)
  • Induced Pluripotent Stem Cells (cytology, drug effects)
  • Mice
  • Mice, Knockout
  • Osteoblasts (cytology, drug effects)
  • Osteoporosis (drug therapy, genetics)
  • Vitamin D (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: